aME relationship between the release of platelet activating factor (PAF), leukotriene C4/D4/E. (LTC4/D4/E) and prostaglandin D (PGD2) from nasal mucosa in vtvo was examined in 24 rhinitis patients allergic to the house dust mite (HDM). During a double blind placebo controlled cross-over study 200 lig fluticasone propionate aqueous nasal spray (FPANS) was administered twice daily for two weeks. In response to allergen provocation (100, 1 000, 10000 Bu/ml) and during the 9.5 h after this challenge the nasal fluid was obtained by washing the nose with saline and the levels of PAF, LTC/D/E and PGD2, as indicators of mediator release, were measured at the following time-points: baseline (t 1/2), allergen provocation with 10 000 Bu/ml (t 0), 3.5 and 7.5 h (late phase). After 
Introduction
In the 1920s house dust allergy was recognized when dust extracts from mattresses and vacuum cleaners were found to give relevant positive reactions in skin test on asthmatics. 1," Since 1964 it has been known that the majority of house dust sensitive patients show positive skin reactions to the mites of the genus Dermatophagoides farinae (Df) and D. pteronyssinus (Dp) as a major source in house dust. The faeces particles, in particular, contain allergenic material in a concentrated form. Practicable control measures, such as chemicals, cleaning, ventilation and temperature regulation have only been able to reduce the number of mites in houses to some extent but the clinical effect has been disappointing. 1 , As long as these methods are insufficient other forms of therapy are needed, such as immuno-therapy and symptomatic medication. House dust mites are the major cause of perennial rhinitis. The pathophysiology of allergic rhinitis, however, has been mainly studied in pollen allergy. Symptom score: Symptoms were scored according to a scoring system described by Lebel et al. 23 These symptoms were observed in order to study the correlation between these clinical symptoms and the inflammatory mediators. The score was compiled before each lavage and after PBS and each allergen insufflation.
Mediator assays: The levels of PAF, LTC4/D4/E4 and PGD,. were measured by Scintillation Proximity Assay (SPA), Biotrak R and Radioimmunoassay (RIA) respectively (Amersham, UK). The limits of sensitivity of the assays were approximately 20, 3.1 and 0.75 pg/ 100 l.tl respectively. Cross-reactivity (50% B/B0 displacement) of: PAF assay, 1-hexadecyl-2-acetyl GPC-PAF(C16:0) (100%), 1-octadecyl-2-acetyl GPC-PAF(C18:0) (40%), racPAF (29%), 1-hexadecyl-2-1yso GPC-Lyso-PAF(C16:0) (< 0.01%); LTC4/D4/E assay: LTC (100%), LTD (100%), LTE (70%), LTB (0.4%) and prostaglandins (< 0.006%); PGD2 assay, PGD2 (100%), PGJ2 (7%), TxB (0.3%), PGF, (0.04%) and other prostaglandins (< 0.02%0). 
Discussion
Lavage of the nasal mucosa appears to be a convenient model for measuring inflammatory mediator release during an allergic reaction to the house dust mite. In agreement with other investigators it was found that within a few minutes of exposure to an allergen leukotrienes and prostaglandins can be measured in nasal washings. 11'24-28 This is the first study in which PAF could be measured in nasal lavages in detectable amounts seen within a few minutes after nasal provocation with house dust mite extract. Other investigators found lyso-PAF but almost no PAF by bioassay in nasal washings after nasal challenge of patients with a pollen allergy. 29, 3 In vitro studies have demonstrated that PAF is released by alveolar macrophages, 31 
